Our unique approach has helped us garner recognition and accolades for our strategy of investing in underappreciated Chinese firms listed on exchanges worldwide.
Our unique approach has helped us garner recognition and accolades for our strategy of investing in underappreciated Chinese firms listed on exchanges worldwide.
Some of our achievements
Heng Ren Silk Road Investments in 2023 was the original plaintiff in the Renren Derivative Lawsuit, Benchmark Litigation's "Impact Case of the Year."
Preqin ranked Heng Ren Silk Road Investments returns from 2018-2022 among the best from hundreds of peers.
Heng Ren Investments' performance from 2013 to 2022 was ranked among the top by Preqin, surpassing many of its peer funds.
Jumei Insiders Withdraw Buyout Bid Under Heng Ren Pressure – Activist Insight
In 2016, China-based, New York-listed Jumei International has decided to reject a buyer group's proposal to take the company private. The online beauty products retailer received a letter from the buyer group stating that they were withdrawing their previous non-binding proposal immediately. The proposal, initially made in February 2016 by the company's founder and CEO, Leo Ou Chen, along with Yusen Dai of Sequoia Capital China, offered $7 per share.
Activist investor Heng Ren Partners criticized Chen and Sequoia Capital China in August for not providing updates on their initial bid, which led to a sharp drop in Jumei's stock price. The stock had fallen by nearly 40% since the start of the year, hovering at around $3. However, following the announcement of the withdrawal, Jumei's shares experienced a 13% surge, followed by another 7% in pre-market trading for a cumulative 20% surge after Heng Ren's actions.
Now is a good time to get started
If you're ready to get invested in the Next China, we're ready to help you.